World Orphan Drug Congress USA 2024

The World Orphan Drug Congress USA brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies for rare disease patients.

"Cell and gene therapy access and reimbursement challenges in Europe" is the title of a panel discussion, moderated by Dr Alexander Natz, Director General, EUCOPE - European Confederation of Pharmaceutical Entrepreneurs. SKC's founder and managing director, Prof. Matthias P. Schönermark M.D., Ph.D. will discuss this important topic together with other industry experts ( 24 April at 4:00 pm). 

We look forward to connecting with you at the World Orphan Drug Congress USA 2024 and sharing our insights and expertise on rare diseases.